These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 6211481

  • 1. Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system.
    Nicholson-Weller A, Burge J, Fearon DT, Weller PF, Austen KF.
    J Immunol; 1982 Jul; 129(1):184-9. PubMed ID: 6211481
    [No Abstract] [Full Text] [Related]

  • 2. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ, Ramsey J, Hammer CH, Frank MM.
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [Abstract] [Full Text] [Related]

  • 3. Murine membrane inhibitor of complement which accelerates decay of human C3 convertase.
    Kameyoshi Y, Matsushita M, Okada H.
    Immunology; 1989 Dec; 68(4):439-44. PubMed ID: 2481641
    [Abstract] [Full Text] [Related]

  • 4. Purification from guinea pig erythrocyte stroma of a decay-accelerating factor for the classical c3 convertase, C4b,2a.
    Nicholson-Weller A, Burge J, Austen KF.
    J Immunol; 1981 Nov; 127(5):2035-9. PubMed ID: 6913607
    [Abstract] [Full Text] [Related]

  • 5. C3 convertases of complement. Molecular genetics, structure and function of the catalytic domains, C2 and B.
    Volanakis JE.
    Year Immunol; 1989 Nov; 4():218-30. PubMed ID: 2648703
    [No Abstract] [Full Text] [Related]

  • 6. The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb.
    Fujita T, Inoue T, Ogawa K, Iida K, Tamura N.
    J Exp Med; 1987 Nov 01; 166(5):1221-8. PubMed ID: 2445886
    [Abstract] [Full Text] [Related]

  • 7. Relationship between the component and regulatory proteins of the classical pathway C3 convertase.
    Welch TR, Forristal J, Beischel L.
    J Lab Clin Med; 1986 Jun 01; 107(6):529-33. PubMed ID: 3635565
    [Abstract] [Full Text] [Related]

  • 8. Differences between the binding sites of the complement regulatory proteins DAF, CR1, and factor H on C3 convertases.
    Pangburn MK.
    J Immunol; 1986 Mar 15; 136(6):2216-21. PubMed ID: 2419425
    [Abstract] [Full Text] [Related]

  • 9. Immunoglobulin-independent utilization of the classical complement pathway in opsonophagocytosis of Escherichia coli by human peripheral leukocytes.
    Leist-Welsh P, Bjornson AB.
    J Immunol; 1982 Jun 15; 128(6):2643-51. PubMed ID: 6210733
    [No Abstract] [Full Text] [Related]

  • 10. Endogenous association of decay-accelerating factor (DAF) with C4b and C3b on cell membranes.
    Kinoshita T, Medof ME, Nussenzweig V.
    J Immunol; 1986 May 01; 136(9):3390-5. PubMed ID: 2420889
    [Abstract] [Full Text] [Related]

  • 11. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator.
    Gigli I, Fujita T, Nussenzweig V.
    Proc Natl Acad Sci U S A; 1979 Dec 01; 76(12):6596-600. PubMed ID: 293746
    [Abstract] [Full Text] [Related]

  • 12. Regulation by membrane sialic acid of beta1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway.
    Fearon DT.
    Proc Natl Acad Sci U S A; 1978 Apr 01; 75(4):1971-5. PubMed ID: 273923
    [Abstract] [Full Text] [Related]

  • 13. Regulation of the C3 nephritic factor stabilized C3/C5 convertase of complement by purified human erythrocyte C3b receptor.
    Daha MR, Kok DJ, Van Es LA.
    Clin Exp Immunol; 1982 Oct 01; 50(1):209-14. PubMed ID: 6216999
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.
    Medof ME, Kinoshita T, Nussenzweig V.
    J Exp Med; 1984 Nov 01; 160(5):1558-78. PubMed ID: 6238120
    [Abstract] [Full Text] [Related]

  • 15. Mechanism of action of the C4 nephritic factor. Deregulation of the classical pathway of C3 convertase.
    Gigli I, Sorvillo J, Mecarelli-Halbwachs L, Leibowitch J.
    J Exp Med; 1981 Jul 01; 154(1):1-12. PubMed ID: 7019379
    [Abstract] [Full Text] [Related]

  • 16. Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria.
    Pangburn MK, Schreiber RD, Müller-Eberhard HJ.
    Proc Natl Acad Sci U S A; 1983 Sep 01; 80(17):5430-4. PubMed ID: 6225118
    [Abstract] [Full Text] [Related]

  • 17. The proteolytic activation systems of complement.
    Reid KB, Porter RR.
    Annu Rev Biochem; 1981 Sep 01; 50():433-64. PubMed ID: 7023363
    [No Abstract] [Full Text] [Related]

  • 18. The biochemistry of complement.
    Porter RR, Reid KB.
    Nature; 1978 Oct 26; 275(5682):699-704. PubMed ID: 703835
    [Abstract] [Full Text] [Related]

  • 19. Isolation of C4-binding protein from guinea pig plasma and demonstration of its function as a control protein of the classical complement pathway C3 convertase.
    Burge J, Nicholson-Weller A, Austen KF.
    J Immunol; 1981 Jan 26; 126(1):232-5. PubMed ID: 6778916
    [Abstract] [Full Text] [Related]

  • 20. [Functions and structure of complement inactivators in membrane proteins. 2). Decay-accelerating factor].
    Sugita Y.
    Nihon Rinsho; 1988 Sep 26; 46(9):1927-32. PubMed ID: 2468004
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.